Lysophosphatidylcholine stimulates IL-1β release from microglia via a P2X7 receptor-independent mechanism

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8560-8568

  Stock, Christian ^a   Schilling, Tom ^b   Schwab, Albrecht ^a   Eder, Claudia ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CASPASE; CATION CHANNEL; CHARYBDOTOXIN; GADOLINIUM; INTERLEUKIN 1BETA; LANTHANUM; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDYLCHOLINE; NIGERICIN; PURINE P2X7 RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HYPERPOLARIZATION; INFLAMMATORY DISEASE; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TISSUE INJURY;

EID: 33845422977     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8560     Document Type: Article

References (56)

1. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
2. Perry, V. H., T. A. Newman, and C. Cunningham. 2003. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4: 103-112.
3. Allan, S. M., P. J. Tyrrell, and N. J. Rothwell. 2005. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5: 629-640.
4. Minami, M., Y. Kuraishi, K. Yabuuchi, A. Yamazaki, and M. Satoh. 1992. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58: 390-392.
5. Vezzani, A., M. Conti, A. De Luigi, T. Ravizza, D. Moneta, F. Marchesi, and M. G. De Simoni. 1999. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19: 5054-5065.
6. Woodroofe, M. N., G. S. Sarna, M. Wadhwa, G. M. Hayes, A. J. Loughlin, A. Tinker, and M. L. Cuzner. 1991. Detection of interleukin-1 and interleukin-6 in adult rat brain, following injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33: 227-236.
7. Giulian, D., T. J. Baker, L. C. Shin, and L. B. Lachman. 1986. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
8. Quan, N., M. Whiteside, and M. Herkenham. 1998. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83: 281-293.
9. Hauser, S. L., T. H. Doolittle, R. Lincoln, R. H. Brown, and C. A. Dinarello. 1990. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735-1739.
10. Martin, D., and S. L. Near. 1995. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61: 241-245.
11. Merrill, J. E., Y. Koyanagi, J. Zack, L. Thomas, F. Martin, and I. S. Chen. 1992. Induction of interleukin-1 and tumor necrosis factor α in brain cultures by human immunodeficiency virus type 1. J. Virol. 66: 2217-2225.
12. González-Scarano, F., and J. Martín-García. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5: 69-81.
13. Griffin, W. S., L. C. Stanley, C. Ling, L. White, V. MacLeod, L. J. Perrot, C. L. White, and C. Araoz. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86: 7611-7615.
14. Yamasaki, Y., N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama, and K. Kogure. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26: 676-680.
15. Stroemer, R. P., and N. J. Rothwell. 1998. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat. J. Cereb. Blood Flow Metab. 18: 833-839.
16. Relton, J. K., and N. J. Rothwell. 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29: 243-246.
17. Sherwin, C., and R. Fern. 2005. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-α, IL-1β, and calcium. J. Immunol. 175: 155-161.
18. Cunningham, C., D. C. Wilcockson, S. Campion, K. Lunnon, and V. H. Perry. 2005. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25: 9275-9284.
19. Yao, J., J. E. Keri, R. E. Taffs, and C. A. Colton. 1992. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591: 88-93.
20. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1 from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582.
21. Ferrari, D., M. Viualba, P. Chiozzi, S. Falzoni, P. Ricciardi-Castagnoli, and F. Di Virgilio. 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156: 1531-1539.
22. Sanz, J. M., and F. Di Virgilio. 2000. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J. Immunol. 164: 4893-4898.
23. Bianco, F., E. Pravettoni, A. Colombo, U. Schenk, T. Möller, M. Matteoli, and C. Verderio. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia. J. Immunol. 174: 7268-7277.
24. 7 receptor channels. J. Neurosci. 22: 3061-3069.
25. 7 receptor: a key player in IL-1 processing and release. J. Immunol. 176: 3877-3883.
26. Sun, G. Y., and F. F. Foudin. 1984. On the status of lysolecithin in rat cerebral cortex during ischemia. J. Neurochem. 43: 1081-1086.
27. Kinouchi, H., S. Imaizumi, T. Yoshimoto, H. Yamamoto, and M. Motomiya. 1990. Changes of polyphosphoinositides, lysophospholipid, and free fatty acids in transient cerebral ischemia of rat brain. Mol. Chem. Neuropathol. 12:215-228.
28. 2 and phospholipids in neural membranes in an experimental epilepsy model. Acta Neurol. Scand. 106: 258-262.
29. Kabarowski, J. H., Y. Xu, and O. N. Witte. 2002. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 64: 161-167.
30. Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730.
31. Ousman, S. S., and S. David. 2000. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30: 92-104.
32. Schilling, T., F. Lehmann, B. Rückert, and C. Eder. 2004. Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J. Physiol. 557: 105-120.
33. Raivich, G., M. Bohatschek, C. U. Kloss, A. Werner, L. L. Jones, and G. W. Kreutzberg. 1999. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev. 30: 77-105.
34. Streit, W. J., S. A. Walter, and N. A. Pennell. 1999. Reactive microgliosis. Prog. Neurobiol. 57: 563-581.
35. 7 receptors. J. Biol. Chem. 278: 30732-30740.
36. + channels for lysophosphatidic acid-induced microglial migration. Eur. J. Neurosci. 19: 1469-1474.
37. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
38. Perregaux, D. G., and C. A. Gabel. 1998. Human monocyte stimulus-coupled IL-1β posttranslational processing: modulation via monovalent cations. Am. J. Physiol. 275: C1538-C1547.
39. Liu-Wu, Y., E. Hurt-Camejo, and O. Wiklund. 1998. Lysophosphatidylcholine induces the production of IL-1β by human monocytes, Atherosclerosis 137: 351-357.
40. Kim, S. H., C. J. Smith, and L. J. Van Eldik. 2004. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol. Aging 25: 431-439.
41. Eder, C. 1998. Ion channels in microglia (brain macrophages). Am. J. Physiol. 275: C327-C342.
42. + currents of ramified murine brain macrophages. Naunyn Schmiedebergs Arch Pharmacol. 356: 233-239.
43. + channels. Neuroscience 109: 827-835.
44. Yao, J., and R. W. Johnson. 1997. Induction of interleukin-1β- converting enzyme (ICE) in murine microglia by lipopolysaccharide. Brain Res. Mol. Brain Res. 51: 170-178.
45. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing monocytes. Nature 356: 768-774.
46. Murgia, M., S. Hanau, P. Pizzo, M. Rippa, and F. Di Virgilio. 1993. Oxidized ATP: an irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268: 8199-8203.
47. MacKenzie, A., H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, and A. Surprenant. 2001. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 15: 825-835.
48. 7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. 285: C286-C299.
49. 2+ entry differentially contribute to the release of IL-1β and IL-1α from murine macrophages, J. Immmol. 170: 3029-3036.
50. Yun, M. R., F. Okajima, and D. S. Im. 2004. The action mode of lysophosphatidylcholine in human monocytes. J. Pharmacol. Sci. 94: 45-50.
51. Mackenzie, A. B., H. Chirakkal, and R. A. North. 2003. Kv1.3 potassium channels in human alveolar macrophages. Am. J. Physiol 285: L862-L868.
52. Perregaux, D., and C. A. Gabel. 1994. Interleukin-1β maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269: 15195-15203.
53. Walev, I., K. Reske, M. Palmer, A. Valeva, and S. Bhakdi. 1995. Potassium-inhibited processing of IL-1β in human monocytes. EMBO J. 14: 1607-1614.
54. Mauler, F., V. Hinz, E. Horvath, J. Schuhmacher, H. A. Hofmann, S. Wirtz, M. G. Hahn, and K. Urbahns. 2004. Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma. Eur. J. Neurosci. 20: 1761-1768.
55. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 98: 13942-13947.
56. Reich, E. P., L. Cui, L. Yang, C. Pugliese-Sivo, A. Golovko, M. Petto, G. Vassileva, I. Chu, A. A. Nomeir, L. K. Zhang, et al. 2005. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. 35: 1027-1036.